NO169390C - Analogifremgangsmaate for fremstilling av terapeutisk aktive kinoxalinderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive kinoxalinderivater

Info

Publication number
NO169390C
NO169390C NO892680A NO892680A NO169390C NO 169390 C NO169390 C NO 169390C NO 892680 A NO892680 A NO 892680A NO 892680 A NO892680 A NO 892680A NO 169390 C NO169390 C NO 169390C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
analogy procedure
compounds
kinoxalin
Prior art date
Application number
NO892680A
Other languages
English (en)
Norwegian (no)
Other versions
NO169390B (no
NO892680D0 (no
NO892680L (no
Inventor
Poul Jacobsen
Flemming Elmelund Nielsen
Tage Honore
Joergen Drejer
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO892680D0 publication Critical patent/NO892680D0/no
Publication of NO892680L publication Critical patent/NO892680L/no
Publication of NO169390B publication Critical patent/NO169390B/no
Publication of NO169390C publication Critical patent/NO169390C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D517/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings
    • C07D517/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO892680A 1988-06-28 1989-06-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinoxalinderivater NO169390C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK356788A DK160941C (da) 1988-06-28 1988-06-28 Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar

Publications (4)

Publication Number Publication Date
NO892680D0 NO892680D0 (no) 1989-06-27
NO892680L NO892680L (no) 1989-12-29
NO169390B NO169390B (no) 1992-03-09
NO169390C true NO169390C (no) 1992-06-17

Family

ID=8124358

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892680A NO169390C (no) 1988-06-28 1989-06-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinoxalinderivater

Country Status (18)

Country Link
US (5) US4977155A (da)
EP (1) EP0348872B1 (da)
JP (1) JPH0248578A (da)
KR (1) KR910000735A (da)
AT (1) ATE95181T1 (da)
AU (1) AU619863B2 (da)
CA (1) CA1326670C (da)
DE (1) DE68909513T2 (da)
DK (1) DK160941C (da)
ES (1) ES2059636T3 (da)
FI (1) FI91259C (da)
IE (1) IE64289B1 (da)
IL (1) IL90733A (da)
NO (1) NO169390C (da)
NZ (1) NZ229730A (da)
PH (1) PH27565A (da)
PT (1) PT91010B (da)
ZA (1) ZA894903B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
US5153195A (en) * 1988-12-22 1992-10-06 Novo Nordisk A/S Quinoxaline compounds and their preparation and use
PT99864B (pt) 1990-12-21 1999-06-30 Schering Ag Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
US5196421A (en) * 1991-06-05 1993-03-23 Eli Lilly And Company Excitatory amino acid receptor antagonists in methods for the use thereof
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
DK162491D0 (da) * 1991-09-20 1991-09-20 Novo Nordisk As Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
DK0647137T3 (da) * 1992-06-22 2008-12-08 State Of Oregon Through Oregon Glycinreceptorantagonister og anvendelse deraf
ES2109516T3 (es) 1992-10-13 1998-01-16 Warner Lambert Co Derivados de quinoxalinodiona como antagonistas de aminoacidos excitadores.
DE4310523A1 (de) * 1993-03-31 1994-10-06 Basf Ag Imidazolo-chinoxalinone zur Behandlung zentralnervöser Erkrankungen
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
US5576323A (en) * 1993-12-03 1996-11-19 Eli Lilly And Company Excitatory amino acid receptor antagonists
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative
US5476851A (en) * 1994-09-08 1995-12-19 Rhone-Poulenc Rorer Pharmaceuticals, Inc. Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase
US5719153A (en) * 1995-08-15 1998-02-17 American Home Products Corporation 5H,8H-2-oxa-1,3,5,8-tetraaza-cyclopenta b!-naphthalene-6,7-diones
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
WO1998013046A1 (en) 1996-09-27 1998-04-02 Guilford Pharmaceuticals Inc. Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
CN1217660C (zh) 1997-01-23 2005-09-07 史密丝克莱恩比彻姆公司 Il－8受体拮抗剂
US6288075B1 (en) 1998-02-26 2001-09-11 Rhone-Poulenc Rorer S.A. Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same
FR2760237B1 (fr) * 1997-02-28 1999-04-16 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
FR2766487B1 (fr) * 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
US6262044B1 (en) 1998-03-12 2001-07-17 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (PTPASES)
WO1999046267A1 (en) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
JP2009286778A (ja) * 2008-04-30 2009-12-10 Sumitomo Chemical Co Ltd ｔｅｒｔ−ブチル３−アミノピペリジン−１−カルボキシレートの製造方法およびその中間体
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions
CN113549087B (zh) * 2020-04-26 2025-09-12 北京鼎材科技有限公司 一种化合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1246578A (en) * 1982-03-29 1988-12-13 John H. Musser 2-oxo-1,3-oxazolo[4,5]quinolines useful as anti-allergy agents
DK146787A (da) * 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
DK356788D0 (da) 1988-06-28
ES2059636T3 (es) 1994-11-16
US5079250A (en) 1992-01-07
IL90733A0 (en) 1990-01-18
AU3707789A (en) 1990-01-04
DE68909513T2 (de) 1994-01-20
FI91259C (fi) 1994-06-10
IE892008L (en) 1989-12-28
US5057516A (en) 1991-10-15
PT91010A (pt) 1989-12-29
PT91010B (pt) 1995-01-31
EP0348872B1 (en) 1993-09-29
NO169390B (no) 1992-03-09
DK160941C (da) 1991-10-21
US5109001A (en) 1992-04-28
US4977155A (en) 1990-12-11
US5075306A (en) 1991-12-24
CA1326670C (en) 1994-02-01
EP0348872A1 (en) 1990-01-03
PH27565A (en) 1993-08-18
NO892680D0 (no) 1989-06-27
NZ229730A (en) 1991-07-26
AU619863B2 (en) 1992-02-06
NO892680L (no) 1989-12-29
FI893170L (fi) 1989-12-29
KR910000735A (ko) 1991-01-30
ATE95181T1 (de) 1993-10-15
DK356788A (da) 1990-03-21
DK160941B (da) 1991-05-06
IL90733A (en) 1994-02-27
FI91259B (fi) 1994-02-28
IE64289B1 (en) 1995-07-26
ZA894903B (en) 1990-03-28
DE68909513D1 (de) 1993-11-04
FI893170A0 (fi) 1989-06-28
JPH0248578A (ja) 1990-02-19

Similar Documents

Publication Publication Date Title
NO892680L (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser.
NO903851D0 (no) Fremgangsmaate for fremstilling av n-substituerte-4-pyrimidinaminer og -pyrimidindiaminer, og deres anvendelse som medikamenter.
NO831613L (no) Dihydropyridinderivater og fremgangsmaate for deres fremstilling.
FI92582B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten kinoksaliinijohdannaisten valmistamiseksi
CA2160444A1 (en) Aroyl-piperdine derivatives
NO965334L (no) Nye 4,6-diarylpyrimidin-derivater og salter derav
CA2131797A1 (en) Condensed indole derivatives as 5ht4-receptor antagonists
DK0565377T3 (da) Terapeutiske midler til behandling af Parkinsons sygdom
CA1272482C (en) QUINOLINECARBOXYLIC ACID DERIVATIVES
SE8204312D0 (sv) Forfarande for framstellning av 1,4-dihydropyridinderivat
KR890001957A (ko) N-아미노부틸-n-페닐아릴아미드 유도체, 그의 제법 및 치료에의 응용
DK519985D0 (da) Quinoloncarboxylsyrederivater, fremgangsmaade til fremstilling deraf og antibakterielt middel indeholdende saadanne derivater
DE69110828D1 (de) Heterozyklische Aminderivate, deren Herstellung und deren Verwendung.
CZ20012144A3 (cs) Sulfonyloxazolaminy jakoľto terapeuticky účinné látky
DK471687A (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
BR0212932A (pt) Derivados de alquilaminopiridazinona substituìdos, processo para a preparação destes, composição farmacêutica contendo os mesmos e seus usos
IE58591B1 (en) Thienopyridine derivatives
DK592589A (da) Kondenserede heterocycliske derivater af 1,2,3,4-tetrahydroacridin, deres fremstilling og anvendelse
HU912901D0 (en) Method for producing 3-(1h-indazole-3-yl)-4-pyridine amines and pharmaceutical preparatives containing said compounds
DK81593D0 (da) Nye isatinoximderivater, deres fremstilling og anvendelse
NO823676L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-furyl-3,4-dihydroisokinolin-derivater
GB1469410A (en) Benzodioxole derivatives
NO934566L (no) Imidazolderivater, fremgangsmåte for deres fremstilling og farmasöytisk preparat derav
ES412248A1 (es) Un procedimiento para la preparacion de sales farmaceuti- camente aceptables de derivados de o2,2'-anhidro-1-(3'0-a- cil-beta-d-arabinofuranosil) citosina.
ATE108444T1 (de) 3-isoxazolonderivate, ihre herstellung und ihre anwendung in der therapeutik.